OpenEvidence, a Miami AI search tool used by doctors, reaches $15 billion valuation
Physicians are turning to an ad-supported chatbot for medical literature during diagnosis and treatment, raising questions about its role in patient care.
A Miami-based AI search startup, OpenEvidence, has reached a $15 billion valuation as a growing share of US physicians use its chatbot to check medical literature and clinical guidelines during diagnosis and treatment. The company says a large portion of the country's roughly one million doctors submitted over 42 million queries in a single recent month. Its growth has come mostly through referrals between clinicians rather than paid marketing, and the platform carries advertising. The founder, a serial entrepreneur who started the company in 2022, calls it the first viral consumer internet app in healthcare, which has sparked debate about how far such tools should shape patient care.
Why it matters
For physicians, OpenEvidence is becoming a routine reference point for checking medical journals and clinical guidelines while making decisions about patients. Its spread through word of mouth among clinicians, rather than paid marketing, means adoption is happening inside medical practice itself. Because the platform carries advertising, the company's commercial interests now sit alongside the clinical information doctors rely on, which is the central point of debate about how far such tools should shape patient care.
Matters or hype?
Does this story matter, or is it hype? Vote before you see what everyone else said.
Sources
- Ars Technica